Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Neutralizing Antibodies

InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) (JN929010)

InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202)
InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202)
Price(USD):
Spec:
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.JN929010
Description
InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202) [Iv0202] (JN929010) is a alpaca monoclonal antibody detecting Protein glycosylation K in ELISA, Neutralization.
Species reactivityCampylobacter jejuni
ApplicationsELISA, Neutralization
Host speciesAlpaca
IsotypeVHH-8His-Cys-tag
Clone IDIv0202
Clonality Monoclonal
Target Protein glycosylation K, 7.5.2.5, pglK, wlaB, Cj1130c
Endotoxin level <0.01 EU/ug
Purity >95% as determined by SDS-PAGE.
Associated products pH 7.4 Dilution Buffer
Purification Purified by Nickel column.
Accession Q0P9C4
Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Background

Protein glycosylation K (wlaB/pglK) is a ~64 kDa protein. Mediates the ATP-dependent translocation of the undecaprenylpyrophosphate-linked heptasaccharide intermediate across the cell membrane; this is an essential step during the N-linked protein glycosylation pathway. Transport across the membrane is effected via ATP-driven conformation changes. Most likely, only the polar and charged part of the glycolipid enter the substrate-binding cavity, and the lipid tail remains exposed to the membrane lipids during the transmembrane flipping process.

Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202)

    SDS-PAGE

    SDS-PAGE for InVivoMAb Anti-Campylobacter jejuni subsp. wlaB/pglK Nanobody (Iv0202).

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list